Smoking cessation using innovative techniques

Target audience

Respiratory physicians, cardiologists, general practitioners, psychologists, social workers, nurses and other allied health professionals.

Educational aims

Identify, analyse and influence individual and social factors affecting smoking persistence.
Rightly incorporate concerns affecting special groups of smokers (adolescents, pregnant women, passive smokers, psychiatric, cardiovascular, COPD, asthmatic and oncology patients).
Choose the best suited pharmalocological treatment for each smoker.
Craft smoking cessation strategies.
Run a smoking cessation clinic.

Download all media

Course programme
Facing the world tobacco epidemic P.J. Barnes (London, United Kingdom)
Epidemiology of smoking related respiratory diseases. The role of ENSP P. Behrakis (Athens, Greece)
ERS advocacy in tobacco control policies J.P. Sculier (Brussels, Belgium)
Smokehaz: new ERS website for policy makers C. Gratziou (Athens, Greece)
Addiction to nicotine and relations to other addictions. Psychological dependence D. Fotopoulos (Rethymno, Greece)
Motivation of smokers and patients with smoking related diseases: the case of COPD B. Dautzenberg (Paris, France)
Pharmaceutical treatments (NRTs) P. Tønnesen (Gentofte, Denmark)
Pharmaceutical treatments (Bupropion) I. Mitrouska (Heraklion, Greece)
Pharmaceutical treatments (Varenicline) P. Katsaounou (Athens, Greece)
ERS position paper on smoking cessation in COPD and other pulmonary disorders C. Jiménez Ruiz (Madrid, Spain)
Review of current guidelines for smoking cessation I. Mitrouska (Heraklion, Greece)
Health benefits and motivators of smoking cessation S. Ravara (Lisboa, Portugal)
Smoking and asthma P.J. Barnes (London, United Kingdom)
Smoking and COPD P. Tønnesen (Gentofte, Denmark)
Smoking and oncology patients J.P. Sculier (Brussels, Belgium)
Smoking cessation in psychiatric patients D. Fotopoulos (Rethymno, Greece)
Smoking cessation in CV diseases S. Tonstad (Oslo, Norway)
Smoking and other systems (endocrinology, urology, etc) P. Argyropoulou-Pataka (Thessaloniki, Greece)
Smoking and pregnancy P. Katsaounou (Athens, Greece)
Smoking in adolescents E. Dagli (Istanbul, Turkey)
Smoking cessation in medical education P. Argyropoulou-Pataka (Thessaloniki, Greece)
How to run a smoking cessation clinic C. Jiménez Ruiz (Madrid, Spain)
Smoking cessation clinics in Europe B. Dautzenberg (Paris, France)
Primary prevention of smoking C. Vardavas (Heraklion, Greece)
Passive smoking and children E. Dagli (Istanbul, Turkey)
Passive smoking and CVD. Implementing advice on SHS exposure in clinical practice S. Ravara (Lisboa, Portugal)
New EU tobacco product directive C. Gratziou (Athens, Greece)
Lapses-relapses M. Toumbis (Athens, Greece)
Treatment of relapses S. Tonstad (Oslo, Norway)
Weight gain and smoking cessation P. Katsaounou (Athens, Greece)
Culturally rooted tobacco products: waterpipes, snus, cigars E. Dagli (Istanbul, Turkey)
New smoking cessation products in the pipeline P. Tønnesen (Gentofte, Denmark)
5A - 5R: Motivational interviewing S. Schoretsaniti (Athens, Greece)